$ATHE· SEC filing ·

ATHE Announces CEO Dr. Stamler to Speak at Bell Potter Healthcare Horizons Summit, Fireside Chat on Optimising Late-stage Clinical Trials, 1-on-1 Investor Meetings, Phase 3 MSA Trial Prep, ATH434 Positive Data, Patent-protected Neurodegenerative Platform

Alterity Therapeutics Limited American Depositary Shares · Now $4.02

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS